AERIE PHARMACEUTICALS, INC. - COMMON STOCK NASDAQ:​AERI

.

Long setup

$42 near-term target.

Aerie Pharmaceuticals is both over bought and is fundamentally not a very good company for these reasons I suggest shorting AERI.NASDAQ:AERI

Contracting vol. NR7 NR3 5ema is still a bit far away; preferred to be touching today's low Inside bar

Great premium income opportunity here! Details are on chart.

I almost ran out of colors, lolz. Looking pretty good for higher to my eyes.

Another Ending Diagonal example from the Pharma industry. These overnight reversals are a beast. I see no signs Aerie is setting up a long. Correction may not be over. Just picked it as a historical ED example.

Becareful with low volume stocks and specially companies that expect FDA approval for any products that are in trial process. This stock formed a bullish pattern that in a rare cases is reliable as well as the bullish harami that was confirmed for Friday's price action. If you decide to take a long position use a tight stop loss at recent swing low at and around ...